Svas Biosana S.p.A. (BIT:SVS)

Italy · Delayed Price · Currency is EUR

8.60

-0.12 (-1.38%)

Last updated: Jul 28, 2026, 10:02 AM CET

Svas Biosana Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.05	33.4	34.25	21.63	30.44
Short-Term Investments	13.32	4	5.75	7.9	0.62
Cash & Short-Term Investments	37.37	37.39	40	29.53	31.06
Cash Growth	-0.05%	-6.53%	35.49%	-4.94%	330.33%
Accounts Receivable	51.14	46.08	41.37	39	31.83
Other Receivables	5.62	4.8	7.84	4.73	3.65
Total Trade Receivables	56.76	50.88	49.21	43.72	35.48
Inventory	39.85	33.97	32.66	29.82	25.13
Other Current Assets	0.9	0.91	0.86	0.74	0.66
Total Current Assets	134.98	123.15	122.73	103.82	92.33
Net Property, Plant & Equipment	27.68	27.11	26.77	26.21	25.64
Other Intangible Assets	12.48	11.54	10.74	10.06	9.7
Goodwill	6.13	0.4	0.68	0.96	1.05
Long-Term Investments	0.04	0.06	0.28	0.52	0.22
Other Long-Term Assets	2.03	1.6	4.5	4.92	6.98
Total Assets	184.91	165.55	165.6	146.23	135.89

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.03	28.85	31	28.2	23.34
Accrued Expenses	0.92	0.77	3.48	3.16	2.68
Short-Term Debt	-	-	25.13	20.73	19.05
Current Portion of Long-Term Debt	-	-	2.15	2.15	2.18
Unearned Revenue	0.05	0.05	0.16	0.1	0.07
Other Current Liabilities	0.64	0.69	3.5	3.48	2.69
Total Current Liabilities	1.65	30.37	65.42	57.82	50.01
Long-Term Debt	-	-	39.9	32.38	33.11
Other Long-Term Liabilities	2.03	1.87	2.04	2.18	2.24
Total Long-Term Liabilities	2.03	1.87	41.93	34.56	35.35
Total Liabilities	3.67	32.24	107.35	92.38	85.36

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	20.6	20.6	20.6	20.6	20.6
Treasury Stock	-4.03	-3.23	-2.92	-2.48	-2
Additional Paid-in Capital	18.21	18.21	18.21	18.21	18.21
Accumulated Other Comprehensive Income	2.45	2.52	2.67	2.9	2.4
Retained Earnings	36.11	30.92	27.16	21.21	16.67
Total Common Shareholders' Equity	67.39	62.83	58.98	54.5	50.96
Minority Interest	0.14	0.01	0.01	0.01	0
Shareholders' Equity	67.53	62.84	58.99	54.51	50.97
Total Liabilities & Equity	184.91	165.55	166.35	146.89	135.89

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0	0	67.18	55.26	54.34
Net Cash (Debt)	37.37	37.39	-27.18	-25.74	-23.28
Net Cash Growth	-0.05%	-	-	-	-
Net Cash Per Share	7.14	7.02	-5.06	-4.75	-6.03
Book Value	67.39	62.83	58.98	54.5	50.96
Book Value Per Share	12.87	11.79	10.99	10.06	13.20
Tangible Book Value	48.77	50.89	47.56	43.48	40.21
Tangible Book Value Per Share	9.32	9.55	8.86	8.03	10.42